DTL
KROS icon

Dynamic Technology Lab’s Keros Therapeutics KROS Stock Holding History

Dynamic Technology Lab’s Portfolio KROS Stock Details KROS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-8,760
Closed -$420K – 1326
2022
Q4 		$420K Buy
+8,760
New +$409K 0.04% 652
2022
Q3 		– Sell
-10,020
Closed -$277K – 1339
2022
Q2 		$277K Buy
+10,020
New +$440K 0.03% 795

Other funds holding KROS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Dynamic Technology Lab's KROS Position: Q1 2023 in Review

Dynamic Technology Lab sold out of Keros Therapeutics (KROS) in Q1 2023, closing a stake of 8,760 shares — an estimated $420K sold.

Dynamic Technology Lab first reported a position in KROS in Q2 2022 and held it in 2 quarters. The position peaked at $420K in Q4 2022. 129 funds tracked by Wall St. Rank hold KROS as of Q1 2023.

  • Dynamic Technology Lab reported no remaining Keros Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Dynamic Technology Lab sold 8,760 Keros Therapeutics shares in Q1 2023, an estimated $420K.
  • Dynamic Technology Lab first reported a position in Keros Therapeutics in Q2 2022 and held it in 2 quarters.
  • Dynamic Technology Lab's Keros Therapeutics position peaked at $420K in Q4 2022.
  • 129 funds tracked by Wall St. Rank held Keros Therapeutics as of Q1 2023.

Based on Dynamic Technology Lab's 13F filing for Q1 2023, filed 12 May 2023.